163 related articles for article (PubMed ID: 37251153)
1. Methoxy-naphthyl-Linked
Abdullaha M; Banoo R; Nuthakki VK; Sharma M; Kaur S; Thakur S; Kumar A; Jadhav HR; Bharate SB
ACS Omega; 2023 May; 8(20):17591-17608. PubMed ID: 37251153
[TBL] [Abstract][Full Text] [Related]
2. Discovery of methoxy-naphthyl linked N-(1-benzylpiperidine) benzamide as a blood-brain permeable dual inhibitor of acetylcholinesterase and butyrylcholinesterase.
Abdullaha M; Nuthakki VK; Bharate SB
Eur J Med Chem; 2020 Dec; 207():112761. PubMed ID: 32942070
[TBL] [Abstract][Full Text] [Related]
3. Blood-brain barrier permeable benzylpiperidin-4-yl-linked benzylamino benzamides as dual cholinesterase inhibitors.
Banoo R; Nuthakki VK; Abdullaha M; Sharma M; Bharate SB
Drug Dev Res; 2022 Dec; 83(8):1791-1802. PubMed ID: 36112736
[TBL] [Abstract][Full Text] [Related]
4. Identification of embelin, a 3-undecyl-1,4-benzoquinone from Embelia ribes as a multitargeted anti-Alzheimer agent.
Nuthakki VK; Sharma A; Kumar A; Bharate SB
Drug Dev Res; 2019 Aug; 80(5):655-665. PubMed ID: 31050027
[TBL] [Abstract][Full Text] [Related]
5. Multitargeted C9-substituted ester and ether derivatives of berberrubine for Alzheimer's disease: Design, synthesis, biological evaluation, metabolic stability, and pharmacokinetics.
Raghuvanshi R; Jamwal A; Nandi U; Bharate SB
Drug Dev Res; 2023 Feb; 84(1):121-140. PubMed ID: 36461610
[TBL] [Abstract][Full Text] [Related]
6. Discovery, molecular dynamic simulation and biological evaluation of structurally diverse cholinesterase inhibitors with new scaffold through shape-based pharmacophore virtual screening.
Yang H; Du C; Li Q; Chen T; Lu X; Li Q; Feng F; Chen Y; Liu W; Sun H
Bioorg Chem; 2019 Nov; 92():103294. PubMed ID: 31557623
[TBL] [Abstract][Full Text] [Related]
7. Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE/BChE inhibitors.
Cheng ZQ; Zhu KK; Zhang J; Song JL; Muehlmann LA; Jiang CS; Liu CL; Zhang H
Bioorg Chem; 2019 Mar; 83():277-288. PubMed ID: 30391700
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of indoloquinoline alkaloid cryptolepine and its bromo-derivative as dual cholinesterase inhibitors.
Nuthakki VK; Mudududdla R; Sharma A; Kumar A; Bharate SB
Bioorg Chem; 2019 Sep; 90():103062. PubMed ID: 31220673
[TBL] [Abstract][Full Text] [Related]
9. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z
Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490
[TBL] [Abstract][Full Text] [Related]
10. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis and Investigation of New Diphenyl Substituted Pyridazinone Derivatives as Both Cholinesterase and Aβ-Aggregation Inhibitors.
Kilic B; Erdogan M; Gulcan HO; Aksakal F; Oruklu N; Bagriacik EU; Dogruer DS
Med Chem; 2019; 15(1):59-76. PubMed ID: 29792155
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, biological evaluation and docking study of 4-isochromanone hybrids bearing N-benzyl pyridinium moiety as dual binding site acetylcholinesterase inhibitors.
Wang C; Wu Z; Cai H; Xu S; Liu J; Jiang J; Yao H; Wu X; Xu J
Bioorg Med Chem Lett; 2015 Nov; 25(22):5212-6. PubMed ID: 26454504
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Biological Evaluation of Coumarin Triazoles as Dual Inhibitors of Cholinesterases and β-Secretase.
Sharma A; Bharate SB
ACS Omega; 2023 Mar; 8(12):11161-11176. PubMed ID: 37008108
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, biological evaluation, and docking study of novel dual-acting thiazole-pyridiniums inhibiting acetylcholinesterase and β-amyloid aggregation for Alzheimer's disease.
Ghotbi G; Mahdavi M; Najafi Z; Moghadam FH; Hamzeh-Mivehroud M; Davaran S; Dastmalchi S
Bioorg Chem; 2020 Oct; 103():104186. PubMed ID: 32890993
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
Gao H; Jiang Y; Zhan J; Sun Y
Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase.
Catto M; Berezin AA; Lo Re D; Loizou G; Demetriades M; De Stradis A; Campagna F; Koutentis PA; Carotti A
Eur J Med Chem; 2012 Dec; 58():84-97. PubMed ID: 23108363
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer's disease.
Meena P; Nemaysh V; Khatri M; Manral A; Luthra PM; Tiwari M
Bioorg Med Chem; 2015 Mar; 23(5):1135-48. PubMed ID: 25624107
[TBL] [Abstract][Full Text] [Related]
19. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Kovaleva NV; Yu Astakhova T; Boltneva NP; Rudakova EV; Serebryakova OG; Proshin AN; Serkov IV; Trofimova TP; Tafeenko VA; Radchenko EV; Palyulin VA; Fisenko VP; Korábečný J; Soukup O; Richardson RJ
Bioorg Chem; 2021 Jul; 112():104974. PubMed ID: 34029971
[TBL] [Abstract][Full Text] [Related]
20. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
Singh YP; Shankar G; Jahan S; Singh G; Kumar N; Barik A; Upadhyay P; Singh L; Kamble K; Singh GK; Tiwari S; Garg P; Gupta S; Modi G
Bioorg Med Chem; 2021 Sep; 46():116385. PubMed ID: 34481338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]